EMA Moves Ahead On New HQ In Amsterdam After Settling Cost Spat
Executive Summary
The EMA is to notify the EU institutions of its intention to sign a contract for its new premises in Amsterdam, after reaching agreement on the costs with the Dutch government.
You may also be interested in...
EMA Queries Cost Of New Dutch HQ As Milan Steps Up Legal Fight
The Dutch government has insisted that the relocation of the European Medicines Agency to Amsterdam will go smoothly and that the agency’s permanent headquarters will be ready on time, despite an argument over the costs of the new premises and a renewed drive by Italy to have the EMA located in Milan.
'Don't Compromise The Pharma Innovation System,' Says Outgoing IFPMA Head Thomas Cueni
Thomas Cueni is stepping down after seven years at the helm of the International Federation of Pharmaceutical Manufacturers and Associations. In an interview with the Pink Sheet ahead of his retirement, he reflects on the proposed pandemic treaty, what still needs to be done to ensure equitable access to medicines, the importance of tackling AMR, moves towards regulatory reliance – and what his post-IFPMA life might look like.
EU Warns Of Life-Threatening Interactions Between Paxlovid & Some Immunosuppressants
The EU’s pharmacovigilance committee says that a review of the available evidence showed that in several cases, blood levels of immunosuppressants increased rapidly to toxic levels in patients who were taking the Pfizer drug.